Selective glucocorticold receptor modulators

被引：23

作者：

Coghlan, MJ

Elmore, SW

Kym, PR

Kort, ME

机构：

[1] Eli Lilly & Co, Lilly Corp Ctr, Discovery Chem Res & Technol, Indianapolis, IN 46285 USA

[2] Abbott Labs, Global Pharmaceut Res & Dev, Abbott Pk, IL 60064 USA

来源：

ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 37 | 2002年 / 37卷

关键词：

D O I：

10.1016/S0065-7743(02)37018-0

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

引用

页码：167 / 176

页数：10

共 91 条

[61] MECHANISMS OF GLUCOCORTICOID ACTION ON IMMUNE PROCESSES [J].

PARRILLO, JE ;

FAUCI, AS .

ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1979, 19 :179-201

[62] NUCLEAR RECEPTOR/AP-1 INTERACTION [J].

PFAHL, M .

ENDOCRINE REVIEWS, 1993, 14 (05) :651-658

[63]

PFIZER PRODUCTS INC, 2000, Patent No. 0066522

[64]

PHILIBERT D, 1991, FRONT HORM RES, V19, P1

[65] Discovery and preliminary SAR studies of a novel, nonsteroidal progesterone receptor antagonist pharmacophore [J].

Pooley, CLF ;

Edwards, JP ;

Goldman, ME ;

Wang, MW ;

Marschke, KB ;

Crombie, DL ;

Jones, TK .

JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (18) :3461-3466

[66]

Ray A, 1995, ANN NY ACAD SCI, V762, P79

[67]

RAY A, 1992, J AM SOC NEPHROL, V2, pS214

[68]

Reichardt HM, 2000, Z RHEUMATOL, V59, P1

[69]

Reichardt HM, 2000, ADV PHARMACOL, V47, P1

[70] Residues in the ligand binding domain that confer progestin or glucocorticoid specificity and modulate the receptor transactivation capacity [J].

Robin-Jagerschmidt, C ;

Wurtz, JM ;

Guillot, B ;

Gofflo, D ;

Benhamou, B ;

Vergezac, A ;

Ossart, C ;

Moras, D ;

Philibert, D .

MOLECULAR ENDOCRINOLOGY, 2000, 14 (07) :1028-1037

← 1 2 3 4 5 6 7 8 9 10 →